Focus on Germany
Report description
While Germany has long been one of Europe's most attractive pharmaceutical markets thanks to free pricing, this is set to change soon under new regulation with particular focus on price negotiations for patent-protected drugs
Please note
These downloads are single copies for your personal use only as specified in our site terms and conditions.
If you are interested in buying bulk copies in either digital or print formats, or you would like to find out how PMLiVE and PMGroup could fulfil your business needs, please see our corporate site, send us a message – or call our sales team on +44 (0)1372 414200.